Insurers may selectively cover emerging cholesterol medication. But those who have taken the injection as part of a clinical trial need to inform the insurer as their risk assessment changes.
Khyati Dharamsi is a freelance finance writer who specializes in personal finance and financial news. With a focus on the national market in India, Khyati writes for moneycontrol.com, providing valuable insights and information on topics such as tax compliance, insurance, investments, and scams. Her articles aim to empower readers with the knowledge they need to make informed financial decisions.